Image 01 Image 03

Medicine Tag

Novavax might give America its fourth COVID-19 vaccine after a trial showed it is 90.4% overall efficient. The vaccine also protects people from moderate and severe COVID-19 in the PREVENT-19 Phase 3 trial.

Of all the organizations issuing untrustworthy guidance and confusing recommendations, perhaps the World Health Organization has been the worst. As we end 2020, with the pandemic lockdowns destroying businesses and driving people to despair, WHO officials are ginning-up more fear.

The second promising coronavirus vaccine from Moderna has tested 94 percent effective at preventing symptomatic illness and appears to prevent the spread of the virus as well. It looks like all systems are go for FDA "emergency use" approval by the end of the week.
The high efficacy of the Moderna vaccine was noted after two doses given 28 days apart. This is about the same level of effectiveness as the Pfizer vaccine.